how retatrutide works long does take to work Retatrutide and the Grey Market:

Clinical Trial Participation Phase 3 trials for Retatrutide include Canadian sites

Biochem J 466: 203218

In 2021, semaglutide was approved by the FDA for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) under the brand name Wegovy

Unlike compounded semaglutide, which lacks standardized testing, regulation, and quality control, these FDA-approved drugs undergo rigorous clinical trials to ensure their safety, efficacy, and consistent dosing

The one saving grace here is that semaglutide is a once-weekly injection, and most of the side effects are temporary